Search research articles
Contact Us
Filters
Showing results (61-70 of 67) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 67 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 16, 2001
MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families
H F Vasen, A Stormorken, F H Menko, et al.
Hereditary Cancer in Clinical Practice
|
April 19, 2016
Intensive breast screening in BRCA2 mutation carriers is associated with reduced breast cancer specific and all cause mortality
D G Evans, E F Harkness, A Howell, et al.
The Journal of Pathology
|
October 31, 2000
Prediction of a mismatch repair gene defect by microsatellite instability and immunohistochemical analysis in endometrial tumours from HNPCC patients
W J de Leeuw, J Dierssen, H F Vasen, et al.
Journal of Medical Genetics
|
April 17, 2008
Screening for familial ovarian cancer: poor survival of BRCA1/2 related cancers
D G Evans, K N Gaarenstroom, D Stirling, et al.
British Journal of Cancer
|
October 27, 2012
The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers
J Iqbal, A Ragone, J Lubinski, et al.
British Journal of Cancer
|
December 3, 2013
Incidence of colorectal cancer in BRCA1 and BRCA2 mutation carriers: results from a follow-up study
C M Phelan, J Iqbal, H T Lynch, et al.
Journal of Medical Genetics
|
November 11, 2008
Risk reducing mastectomy: outcomes in 10 European centres
D G R Evans, A D Baildam, E Anderson, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 67) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 67 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 16, 2001
MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families
H F Vasen, A Stormorken, F H Menko, et al.
Hereditary Cancer in Clinical Practice
|
April 19, 2016
Intensive breast screening in BRCA2 mutation carriers is associated with reduced breast cancer specific and all cause mortality
D G Evans, E F Harkness, A Howell, et al.
The Journal of Pathology
|
October 31, 2000
Prediction of a mismatch repair gene defect by microsatellite instability and immunohistochemical analysis in endometrial tumours from HNPCC patients
W J de Leeuw, J Dierssen, H F Vasen, et al.
Journal of Medical Genetics
|
April 17, 2008
Screening for familial ovarian cancer: poor survival of BRCA1/2 related cancers
D G Evans, K N Gaarenstroom, D Stirling, et al.
British Journal of Cancer
|
October 27, 2012
The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers
J Iqbal, A Ragone, J Lubinski, et al.
British Journal of Cancer
|
December 3, 2013
Incidence of colorectal cancer in BRCA1 and BRCA2 mutation carriers: results from a follow-up study
C M Phelan, J Iqbal, H T Lynch, et al.
Journal of Medical Genetics
|
November 11, 2008
Risk reducing mastectomy: outcomes in 10 European centres
D G R Evans, A D Baildam, E Anderson, et al.
Page
of 7